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The use of complementary and alternative
medicine after the completion of hospital
treatment for colorectal cancer: findings
from a questionnaire study in Denmark
Nina Nissen1*, Anita Lunde2, Christina Gundgaard Pedersen3 and Helle Johannessen1
Abstract
Background: Little is known about the use of complementary and alternative medicine (CAM) for colorectal cancer,
despite the high incidence of colorectal cancer and the frequency of CAM use for cancer-related symptoms. This is the
first Danish study to examine the use of CAM by individuals who completed hospital treatment for colorectal cancer.
Methods: In 2011–12, a pragmatic trial on energy healing as rehabilitation after colorectal cancer was conducted in
Denmark with participants who had completed cancer-related hospital treatment within the past 18 months prior to
study inclusion. As part of the trial, participants (n = 247) completed a questionnaire on the use, motivations, pathways
and perceived benefits of CAM. Socio-demographic information was obtained via the Danish National Patient Registry
and self-report. Descriptive statistics were generated, using SPSS, version 18, and logistic regression analysis was
carried out.
Results: Of 247 individuals, 49.4% used some form of CAM in the past month. Nearly half of the CAM users (49.2%)
used natural medicines and/or dietary supplements only; 32% consulted an alternative therapist; 18.9% used both.
Those who consulted alternative therapists were most commonly women (OR: 3.36; p = .002; CI: 1.54-7.33) with high
educational levels (OR: 2.77; p = 0.010; CI: 1.28-6.01); more women than men used natural medicines and/or dietary
supplements (OR: 1.83; p = .047; CI: 1.01-3.30) independent of educational levels. A majority commenced CAM on their
own initiative; CAM was predominantly used to achieve better physical wellbeing. Beneficial effects were reported
particularly in relation to physical health; few harmful effects were reported. Of those using CAM, 51.5% did not disclose
its use to their physician; 8.5% of participants reported to have been asked by their physician about CAM use.
Conclusion: The use of CAM following completion of hospital treatment for colorectal cancer seems widespread in
Denmark. The identified extensive CAM use suggests a need for more reliable and diverse information about CAM for
both patients and biomedical providers, and improved communication about its use in the clinical context.
Background
In 2012, colorectal cancer was estimated to be the sec-
ond most common form of cancer diagnosed in Europe
and the second most common cause of death from
cancer [1]. In the same year, Denmark was estimated to
have the highest age-standardised rate of colorectal
cancer incidence in Northern Europe, with the highest
mortality rate in women and the third highest mortality
rate in men [1]. People with colorectal cancer experi-
ence poor quality of life following surgery and treat-
ment, and continue to experience a wide range of side
effects after treatment [2-4]. This may make daily activities
difficult [5,6].
Research into patterns of the use of complementary
and alternative medicine (CAM) consistently shows that
the majority of CAM users in European countries, in-
cluding Denmark, take recourse to CAM in conjunction
with biomedical treatments and for a variety of reasons
[7-10]. Main reasons for CAM use focus on symptom
relief and the promotion of well-being and quality of life
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in chronic health conditions and life-threatening illness
such as cancer [7-10]. As some CAM use may have
clinical implications, including clinically significant drug
interactions and potentially adverse interactions with anti-
cancer agents [11,12], knowledge about the use of CAM in
cancer and individual cancers is highly relevant.
Despite the frequency of colorectal cancer, little seems
to be known about the use of CAM by this group of
patients. According to Molassiotis et al’s [10] cross-
sectional survey in various European countries (not
including Denmark) 32% of people diagnosed with colo-
rectal cancer use some form of CAM post-diagnosis. A
colorectal cancer diagnosis is noted to lead to a dramatic
increase in CAM use, particularly the use of herbs,
medicinal teas and spiritual practices [10]. A population-
based study in Alberta (Canada) reports that 49% of
colorectal cancer patients used some form of CAM and
69% did so after conventional care [13]; a study based
on the colon disease registry at a New York City hospital
[14] reports that 75% of colorectal cancer survivors used
some form of CAM. CAM use by individuals with colo-
rectal cancer and/or post-completion of cancer treat-
ment, like cancer patients generally, aims to improve
general health and wellbeing [10,15].
In 2011–12, a pragmatic trial on energy healing as
rehabilitation after completed hospital treatment for
colorectal cancer was conducted in Denmark in order to
test guidelines for effectiveness studies measuring per-
sonalized treatment goals [16-20]. As part of this trial,
an eight-item questionnaire examined participants’ use
of CAM in the month prior to inclusion in the trial, with
the aim to explore respondents’ prevalence of CAM use,
CAM users’ motivations, pathways and perceived bene-
fits and harm resulting from the use of CAM, and com-
munication with physicians about CAM (see Additional
file 1). This article reports on this questionnaire, which
is the first study in Denmark to have examined the use
of CAM by people who have completed hospital treat-
ment for colorectal cancer. The reported CAM use in
the past month allows for a snapshot of respondents’
use of CAM, although its use may be unrelated to can-
cer rehabilitation. To contextualize the identified preva-
lence of CAM use in colorectal cancer which affects
men and women almost equally, findings are compared
to CAM use by Danish cancer patients in general, and
in relation to breast and prostate cancer, as examples of
gender-specific cancers.
Methods
An eight-item questionnaire about the use of CAM and
natural medicines/dietary supplements during the past
month constituted part of a larger baseline questionnaire,
which was completed by all participants (n = 247) in the
pragmatic trial mentioned above. Eligible trial participants
were identified from the Danish National Patient Registry
and invited to take part in the trial. Eligibility criteria
included: 1) primary diagnosis of colorectal cancer, defined
as C18- C20 (ICD10); 2) completed treatment with surgery
or surgery and chemotherapy and/or radiotherapy in the
Southern or Central Region of Denmark between 1 March
2010, and 1 August 2011, and no evidence of current can-
cer; and 3) aged ≤ 80 at inclusion. Patients were excluded if
they: 1) were unable to comply with the data collection
protocol, 2) had poor understanding of the Danish lan-
guage, or 3) were receiving palliative care or had a recur-
rence of cancer prior to inclusion. Thus, all respondents
had completed hospital treatment for colorectal cancer,
were considered to be free of cancer disease, and were at
different stages of cancer rehabilitation.
The eight-item questionnaire comprised multiple-choice
and categorical response questions, including some open
response options. The topics examined were: use of listed
alternative treatments in the past month; use of natural
medicines/dietary supplements in the past month; path-
ways to the use of alternative treatment and/or natural
medicines/dietary supplements; reasons for use and non-
use of CAM; communication with physicians about CAM;
and perceived beneficial and/or harmful effects resulting
from CAM use. To enhance comparability across different
studies, the questions were based on a previous question-
naire about CAM use by cancer patients in 14 European
countries [21], adapted to the Danish context and piloted
at the oncology department at Odense University Hospital,
Denmark. The list of complementary and alternative medi-
cine used by Molassiotis et al. [21] was replaced with a list
of treatments commonly used in Denmark (see Table 1)
Table 1 List of alternative treatments and natural
medicines and/or dietary supplements
Alternative treatments Natural medicines and/or dietary
supplements
Massage, osteopathy and other
manipulative therapies
For example:
Reflexology Pills (such as homeopathic pills)
Acupuncture Tablets or capsules (such as herbal,
vitamins/minerals or food supplements)
Healing (laying-on-of-hands
or similar)
Medicinal teas
Cranio-sacral therapy Extracts (such as herbal
or homeopathic)
Homeopathy
Dietary/nutritional therapy
Kinesiology
Hypnosis
Mindfulness/meditation
Other
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[22]. In addition, a single item question measured respon-
dents’ attitude towards CAM, using a 5-point Likert scale
ranging from very negative to very positive; the item was
developed for the present study instead of using lengthier
validated questionnaires that measure attitude.
In Denmark, most forms of CAM are provided outside
the public healthcare system. In line with Danish regula-
tions and conventions, the questionnaire used the term
‘alternative treatment’ to refer to the field of CAM in
general and to individual treatments or therapies; the
term ‘natural medicines and/or dietary supplements’
referred to the use of medicinal/nutritional products
specifically (see Table 1) [23]. In this article, the term
CAM is used when all forms of uses are referred to
collectively; the term CAM is also used when refer-
ring to international literature, adopting the referenced
author/s’ use of the term.
Ethics
The study adhered to the ethical requirements of the
Helsinki Declaration. Participants received both written
and oral information about the study, and were informed
that they were free to withdraw any time during the
study period. The study was presented to the regional
Committee of Research Ethics in Southern Denmark;
the Committee decided that it did not require their
approval. The study was approved by the Danish Data
Protection Agency.
Analysis
Completed questionnaires were digitalised (Teleform
software) and the data analysed by AL and CGP using
SPSS, version 18. Descriptive statistics were generated and
unadjusted associations with use of alternative treatments
and natural medicines/dietary supplements were assessed
by Chi2, t-tests, or logistic regression analysis. Subse-
quently, a logistic regression model was used to evaluate
the association of each variable with use of CAM and nat-
ural medicines/dietary supplements adjusted for the influ-
ence of other variables; the fully adjusted analysis included
age, gender, educational level and household income. Re-
sults are presented as adjusted odds ratios (OR). Analysis
was conducted using a significance level of 5%.
Results
Demographic details of study participants
Of the individuals identified in the Danish National
Patient Registry and invited to participate in the prag-
matic trial (n = 783), 247 took part in the trial (31.5% of
invited individuals; men: n = 115, 46.6%; women: n = 132,
53.4%). Participants’ mean age was 64 (age range 36–80),
with near equal distribution of those aged 64 and under,
and those aged 65 and over; more women (n = 76; 30.8%)
were in the younger age group, and more men (n = 71;
28.7%) in the older age group (X2(df 1) = 9.178; p = 0.002).
The majority of participants (n = 148; 59.9%) had received
chemotherapy and/or radiotherapy in addition to surgery
(see Table 2).
Attitudes to CAM and the use of alternative treatments
and natural medicines/dietary supplements
Almost half of the participants in the trial as a whole
(n = 247) considered themselves to have ‘very positive’ and
‘positive’ attitudes (45.5%) to CAM; 42% described their
attitudes as ‘neutral’ and 12.4% as ‘negative’. In this study,
49.4% of respondents (n = 122; women: n = 79, 64.8%; men:
n = 43, 35.2%) used some form of CAM in the past month.
A quarter of respondents (25.1%; n = 62; women: n = 47;
men: n = 15) had received some form of alternative treat-
ment, while 40.1% of respondents (n = 99; women: n = 64;
men: n = 35) used natural medicines and/or dietary sup-
plements. Of those using CAM, 49.2% (n = 60) used only
natural medicines/dietary supplements, 32% (n = 39) con-
sulted an alternative therapist for treatment, and 18.9%
(n = 23) used both.
Amongst the CAM users, more women than men
received alternative treatments (women: n = 47; 75.8%;
men: n = 15; 24.2%), with 66.1% aged 65 and under. As
can be derived from Table 3, there was a statistically sig-
nificant relationship between different levels and length
of education: people with higher education (tertiary
degree or higher) more frequently took recourse to alter-
native treatments than those with primary and lower
secondary education only (77%, n = 47; 23%, n = 14;
respectively, 1 participant missing).
The majority (n = 64, 64.6%) of users of natural medi-
cines and/or dietary supplements were also women
Table 2 Participants’ basic demographic details (n = 247)
Number of participants %
Sex:
Women 132 53.4
Men 115 46.6
Age: Range [36–80]
Mean 64.06; SD [8.842]
Cancer treatment: Range [0–116; number of
chemo/radio treatments]
Mean 14.02; SD [21.857]
Surgery 99 40.1
Surgery + chemo/radio 148 59.9
Months since Surgery:
0-5 months 54 21.9
6-9 months 61 24.7
10-13 months 68 27.5
14-17 months 64 25.9
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(men: n = 35, 35.4%), with 57% aged 65 and under. As
indicated in Table 3, a relationship between length and
levels of education and the use of natural medicines/
dietary supplements was noticeable, with 61 participants
(62.9%) having had a tertiary education and 36 partici-
pants (37.1%) having had a lower or upper secondary
education. That is to say, those who consulted alterna-
tive therapists were most commonly women (OR: 3.36;
p = .002; CI: 1.54-7.33) with high educational levels (OR:
2.77; p = 0.010; CI: 1.28-6.01), and more women than
men used natural medicines and/or dietary supplements
(OR: 1.83; p = .047; CI: 1.01-3.30) independent of educa-
tional levels.
Amongst those consulting an alternative practitioner
for treatment, the most common therapies were: massage
(n = 26; 41.9%), acupuncture (n = 19; 30.6%), mindfulness/
meditation (n = 17; 27.4%), reflexology (n = 9; 14.5%) and
cranio-sacral therapy (n = 7; 11.3%). One or a combination
of two therapies was used most frequently (58.1%, n = 36;
29%, n = 18; respectively); 12.8% (n = 8) used between 3
and 5 therapies. Respondents using natural medicines
and/or dietary supplements commonly used fish oils
(n = 43, 43%), vitamins (especially Vitamin C and D, and
multi-vitamins) (n = 39, 39%), fibre (n = 20, 20%), and
calcium (n = 16, 16%). Half of these respondents used one
kind of natural medicines and/or dietary supplements and
the other half combined two or three kinds, with vitamins,
fish oils and calcium being popular combinations.
Pathways to CAM use
Of the respondents receiving alternative treatments
66.1% (n = 41) self-initiated such treatments, whereas
amongst those using natural medicines/dietary supple-
ments 54% (n = 54) did so. Of lesser importance were
suggestions by family and friends (alternative treatments
17.7% (n = 11); natural medicines/dietary supplements
22.2% (n = 22). Health professionals also suggested CAM
use; 34.3% (n = 34) of respondents reported suggestions
from health professionals on the use of natural medi-
cines/dietary supplements, while 9.7% (n = 6) reported
suggestions on the use of alternative treatments. Other
sources of advice mentioned by respondents included
CAM practitioners, other patients, patient organisations,
work colleagues, and print and broadcast media.
Reasons for the use or non-use of CAM
Amongst those respondents who used CAM (n = 122),
the most frequent reason for CAM use concerned the
aim to achieve ‘better physical well-being’ (51 responses;
41.8%). Also prominent was the wish ‘to do something
actively’ (29 responses; 23.8%) and the consideration that
‘maybe CAM helps and doesn’t do any harm’ (29 re-
sponses; 23.8%). For further details, see Table 4.
Amongst those respondents who did not use CAM
(n = 125) the most frequent reasons related to never
having considered CAM use (83 responses; 66.4%) and
Table 3 Sociodemographic variables and educational level dichotomized (n = 122)
Alternative treatments Natural medicines/dietary supplements
Unadjusted Fully Adjusteda Unadjusted Fully Adjusteda
OR P CI OR P CI OR P CI OR P CI
Age 0.94 .001 0.91-0.98 0.96 .064 0.94-1.00 0.98 .141 0.95-1.01 0.99 .743 0.96-1.03
Gender
Male Referent Referent Referent Referent
Female 3.69 <.001 1.93-7.06 3.36 .002 1.54-7.33 2.15 .004 1.27-3.63 1.83 .047 1.01-3.30
Educational level
< tertiary degree Referent Referent Referent Referent
> tertiary degree 4.58 <.001 2.35-8.90 2.77 .010 1.28-6.01 2.23 .003 1.32-3.78 1.59 .131 0.87-2.89
Household income 1.33 .001 1.13-1.57 1.13 .208 0.93-1.38 1.13 .110 0.97-1.30 1.05 .551 0.89-1.25
OR = Odds Ratios. CI = Confidence Interval. OR in bold differs significantly (95% CI) from the reference group (OR = 1.00).
aFully adjusted analysis included age, gender, educational level, and household income in the multiple binary logistic regression analysis.
Table 4 Reasons for CAM use (n = 122)
Reasons Number of responses
(n = 217; several
responses possible)
%
Better physical well-being 51 41.8
Maybe it helps, and doesn’t do any harm 29 23.8
To do something actively 29 23.8
Support the body’s ability to fight the
disease
24 18.9
Better mental/psychological well-being,
e.g. to give hope, optimism
20 16.4
Counteract the negative side-effects of
cancer or the medical treatment
17 13.9
To do everything to fight the disease 15 12.3
Effect on the disease itself 11 9
Other 21 15.6
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being satisfied with conventional treatment (52 responses;
41.6%). For further details, see Table 5.
Perceived effects of CAM
A majority of respondents experienced some beneficial
effects that they attributed to CAM use (see Table 6); ‘no
beneficial effects’ were reported only 13 times (10.7%).
Beneficial effects were reported particularly in relation to
perceived ‘better physical wellbeing’ (38 responses, 31.1%)
and ‘the improvement of mental/psychological wellbeing’
(30 responses, 24.6%).
Asked about harmful effects as a result of CAM use, a
majority of respondents reported not to have experi-
enced any negative consequences (83 responses; 68%).
Negative effects were reported 9 times (7.3%) including
‘nausea and uneasiness’, ‘gastric ulcer’, ‘influence on
blood samples’, ‘weight loss’, and ‘others’ (each reported
in 1–3 responses); 24.7% respondents did not complete
the question about perceived harmful effects.
Communication about CAM with a medical doctor
Of those respondents using some form of CAM, 51.5%
(n = 51) reported not to have informed their doctor
about their CAM use. Of the whole study sample (n = 247)
8.5% (n = 21) reported to have been asked about CAM use
by their doctor.
Discussion
This is the first Danish study that examined the use of
CAM by individuals who completed hospital treatment
for colorectal cancer, and thus contributes to the under-
researched field of CAM use for colorectal cancer. To
contextualise the identified prevalence of CAM use
among persons who had colorectal cancer, in the follow-
ing we compare our findings with 1) studies of CAM
use by Danish cancer patients in general, 2) the use of
CAM in relation to breast and prostate cancer as exam-
ples of gender-specific cancers, and 3) international
literature on CAM use among persons who had (or have)
colorectal cancer.
Our study revealed a relatively high rate of CAM use
after the completion of hospital treatment for colorectal
cancer, when compared with the use of CAM by cancer
patients generally in Denmark, and the use of CAM by
Danish women diagnosed with breast cancer. In our
study, 49.4% of participants used some form of CAM in
the past month, a rate which is significantly higher than
the use of CAM by cancer patients in general, reported
to be 27% [8]; in turn, prevalence of CAM use by cancer
patients across diverse cancers is only slightly higher
than the use of CAM in the past year by the Danish
population in general which was reported to be 26.3%
(31.3% women; 21.1% men) in 2010 [22].
Our study identified that 64.8% women used some
form of CAM in the past month. By comparison, a study
of Danish women diagnosed with breast cancer reports
that 40.1% of participating women used one or more
types of CAM 3–4 months post-surgery [24]. Thus,
women’s high rate of CAM use following colorectal
cancer treatment when compared with the use of CAM
by Danish breast cancer patients post-surgery seems
surprising.
Women are well known, nationally and internationally,
to be the main users of CAM [7,22], including in cancer
in Europe [21]. This raises the question of how our find-
ings of high CAM use in colorectal cancer in Denmark
compare with the prevalence of CAM use in the case
of prostate cancer, the most common cancer to affect
men [1], and where low CAM use could be anticipated.
No Danish studies of CAM use in prostate cancer were
identified, however a German study [25] reports that
47% of participants used some form of CAM within
the past 4 weeks.a These findings indicate that men’s
use of CAM in prostate cancer in Germany is higher
than men’s CAM use in colorectal cancer in Denmark
(35.2%).
Table 5 Reasons for non-use of CAM (n = 125)
Reason Number of responses
(n = 177; several
responses possible)
%
I never thought about having CAM 83 66.4
I am satisfied with the conventional
treatment I received
52 41.6
I cannot afford to pay for CAM 13 10.4
I don’t believe in CAM, as it has not
been tested thoroughly
12 9.6
I am having a break from using CAM 6 4.8
I stopped using CAM 2 1.6
I was advised against having CAM 1 0.8
Other 8 6.4
Table 6 Perceived effects of CAM (n = 122)
Perceived effects Number of responses
(n = 120; several
responses possible)
%
Better physical well-being 38 31.1
An improvement of mental/psychological
well-being, more hope and optimism
30 24.6
No beneficial effect 13 10.7
Reduction of side-effects from cancer
and/or cancer treatment
10 8.2
Strengthening of body’s own ability to
fight cancer
7 5.7
No direct effect on cancer 2 1.6
Other 20 16.4
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Lastly, when comparing our findings with international
studies on the use of CAM in colorectal cancer the
following can be noted: In different European countries,
between 25% and 80% (mean 32%) of colorectal cancer
patients (no gender details provided) are reported to use
CAM post-diagnosis, with a sharp increase of CAM use
noted following diagnosis [10]. Further, a population-
based study in Alberta (Canada) reports that 69% of
participants (59% women; 42% men) used some form of
CAM after conventional care for colorectal cancer [13].
Neither of these studies confirms our findings, but
diverse research designs and study populations, different
national contexts, and heterogeneous notions of CAM
limit international comparisons [7].
Given these diverse national, international and gender-
specific findings and inconclusive comparisons, how can
the results concerning the prevalence of CAM use in
colorectal cancer in Denmark be interpreted? In the
following, we suggest that a consideration of a study’s
wider context reveals aspects that may explain participants’
high CAM use. Our study formed part of a pragmatic trial
on energy healing as rehabilitation for colorectal cancer,
whereby 45.5% of trial participants described their attitude
to CAM as ‘very positive’ or ‘positive’, and 42% as ‘neutral’.
These attitudes to CAM may possibly indicate receptive-
ness to energy healing as a form of cancer rehabilitation,
which – in turn - may also be reflected in the reported
high use of CAM by male and female participants. Fur-
ther, in Germany CAM is frequently practiced by med-
ical doctors, enhancing the status of CAM and possibly
implying positive attitudes to CAM [26]. This may lead
to high rates of CAM use by German men with pros-
tate cancer. Similarly, Tough el al ([13], p54) note that
‘having therapy options other than conventional treat-
ment recommended by conventional doctors’ as one of
the strongest predictors of CAM use in their sample.
Therefore, akin to our study and Bruns et al’s [25] sam-
ple, Tough et al’s [13] sample seems to be characterized
by particular experiences and attitudes towards CAM
which may be implicated in participants’ high preva-
lence of CAM use after conventional care for colorectal
cancer. In summary, the relatively high use of CAM in
our study, as well as in Tough et al’s [13] and Bruns et al’s
studies [25], may be the result of ‘facilitative’ circum-
stances, that is, study participants’ and/or their medical
professionals’ positive attitudes to CAM (see also [26]).
Beyond prevalence of CAM use, our study also identi-
fied other patterns related to CAM use following treat-
ment for colorectal cancer. The majority of respondents
self-initiated their use of CAM or followed suggestions
by family and friends. The importance of social networks
in prompting CAM use is well established in the wider
literature on CAM use [26], including for cancer pa-
tients in Denmark [8]. In particular, in countries where
CAM is largely practiced outside national healthcare
provision, such as Denmark, citizens tend to use their
social network as main information source, although
they may also wish to receive information about CAM
from biomedical professionals [26].
In using CAM, the respondents in our study, like
other cancer patients in Denmark [8,9], aimed to address
physical concerns and symptoms and to contribute ac-
tively to improving their health and well-being. The wish
to be actively involved in caring for one’s health is fre-
quently seen by CAM users generally as one of the at-
tractions of CAM [26]. On the other hand, ‘never having
thought about using CAM’ was given by respondents in
our study as the most common reason for not using
CAM. The lack of information about CAM and/or spe-
cific CAM therapies is also recognized in other studies
as centrally contributing to the non-use of CAM [26].
As a result, some cancer patients express a wish for
more, and particularly trustworthy, information, for ex-
ample through telephone advice lines [8] or through na-
tional health service provision [27]. In the absence of
such information, CAM users predominantly rely on
personal experiences of, for instance, the perception of
beneficial (and/or harmful) effects of CAM, as reported
here and also previously by others [8,9,26].
About half of the respondents in our study, like other
cancer patients in Denmark [8,9], did not disclose their
CAM use to their physician. This is not to suggest that
users would not like to discuss their CAM use with their
doctor or oncologist [8,9,26], but may reflect users’
concerns about or experiences of negative reactions to
their choice of healthcare [9,15,26] and some biomed-
ical professionals’ lack of knowledge about CAM (for
details, see [28]). The literature on patterns of disclos-
ure of CAM use to biomedical professionals also indi-
cates CAM users’ understanding that CAM addresses
other issues and problems than biomedical treatment,
or that biomedical providers do not need to know
about CAM use [26]. This suggests that more access-
ible and reliable information about CAM and improved
communication in the clinical context about the use of
CAM and acknowledgment of its widespread use in
colorectal cancer is of relevance to patients and profes-
sionals alike. EU patients have the right to receive com-
prehensive and easily understood information about
their health and healthcare from their healthcare pro-
vider [29] and patients’ access to diverse, reliable and
trustworthy information, including about CAM, increases
their ability to make informed healthcare decisions
[26,28]. At the same time, biomedical providers’ in-
creased knowledge about CAM and the obtaining of
details about patients’ CAM use may prevent drug interac-
tions and potentially adverse interactions with anti-cancer
treatments [11,12].
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Limitations
Some limitations to the questionnaire study presented
can be noted. A selection bias may have influenced the
results presented, as only 31.5% of eligible individuals
from a national Danish cohort participated (for details
on trial participants and non-participants, see [30]). Fur-
ther, since participants had completed hospital treatment
for colorectal cancer up to 18 months prior to study in-
clusion it is difficult to ascertain whether their CAM use
within the past month related to the cancer from which
they had suffered. In addition, in Denmark, a distinction
is made between alternative treatments, natural medi-
cines and dietary supplements at the juridical level
[23,31]; respondents may however have used these terms
interchangeably, leading to an over- or underreporting of
different forms of CAM use. Also, those respondents
using particular natural medicines and/or dietary supple-
ments may not think of these products as medicines or a
supplement, possibly underreporting their use.
Conclusion
The use of CAM following completion of hospital treat-
ment for colorectal cancer seems widespread in Denmark.
Of 247 individuals who completed hospital treatment for
colorectal cancer in Denmark, 49.4% (64.8% women;
35.2% men) used some form of CAM within the past
month; of those using CAM, 49.2% used only natural
medicines/dietary supplements, 32% consulted an alter-
native therapist for treatments, and 18.9% used both.
Women with higher educational levels were the typical
users of alternative treatments provided by an alternative
practitioner; more women than men used natural medi-
cines and/or dietary supplements independent of educa-
tional levels. The identified widespread use of CAM
suggests a need for more reliable and diverse information
about CAM and improved communication in the clinical
context. Addressing these issues can support patients’
rights to healthcare information and their wish to make in-
formed healthcare decisions, as well as biomedical profes-
sionals’ endeavours to protect patients from potentially
adverse interactions between biomedical treatment and
CAM treatments or natural medicines and/or dietary
supplements.
Endnote
aTo enhance comparability across the different studies
discussed here, studies selected for comparison were re-
stricted to those that most closely resemble our study de-
sign and geographical region. For other studies, see [32].
Additional file
Additional file 1: Questionnaire: Alternativ behandling.
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